In Spite of Good Results with ‘Inject and Cut’, Should We Scrutinize It? –Yes, We Should!

Publisher： Karger

E-ISSN： 1421-9867|82|4|211-212

ISSN： 0012-2823

Source： Digestion, Vol.82, Iss.4, 2010-06, pp. : 211-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Should we treat prehypertension?

By Kjeldsen Sverre E.   Oparil Suzanne   Narkiewicz Krzysztof   Hedner Thomas  

Blood Pressure, Vol. 18, Iss. 6, 2009-12 ,pp. : 298-299

Informa Healthcare

Access to resources Recommend Favorite

How should we report on perinatal outcome?

By Land Jolande A.  

Human Reproduction, Vol. 21, Iss. 10, 2006-10 ,pp. : 2638-2639

Oxford University Press

Access to resources Recommend Favorite

Biomarkers and Pneumonia: Should We All be Using Them?

By  

Current Respiratory Medicine Reviews, Vol. 7, Iss. 4, 2011-08 ,pp. : 262-267

Bentham Science Publishers

Access to resources Recommend Favorite

Trends of SAPHO Therapy: Should we be Content?

By  

Current Rheumatology Reviews, Vol. 9, Iss. 1, 2013-02 ,pp. : 28-33

Bentham Science Publishers

Access to resources Recommend Favorite

How Should We Assess Diastolic Function in Hypertension?

By Bojö Leif   Wandt Birger   Haaga Sophie  

Scandinavian Cardiovascular Journal, Vol. 34, Iss. 4, 2000-10 ,pp. : 377-383

Informa Healthcare

Access to resources Recommend Favorite